Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer

An increasing prostate-specific antigen (PSA) level during radium therapy for metastatic castrate-resistant prostate cancer (mCRPC) is not an uncommon phenomenon, especially in heavily pretreated patients; however, an increasing PSA level does not always indicate progressive disease. Bone scan, ches...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Genitourin Cancer
Main Authors: Modi, Dipenkumar, Hwang, Clara, Mamdani, Hirva, Kim, Seongho, Gayar, Hesham, Vaishampayan, Ulka, Joyrich, Richard, Heath, Elisabeth I.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849387/
https://ncbi.nlm.nih.gov/pubmed/27053499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2016.03.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados